36 results on '"Wit, Ferdinand W N M"'
Search Results
2. Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV
3. Effect of the introduction of screening for cancer precursor lesions on anal cancer incidence over time in people living with HIV: a nationwide cohort study
4. Long-Term Virological Treatment Outcomes in Adolescents and Young Adults With Perinatally and Non-Perinatally Acquired Human Immunodeficiency Virus
5. One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor
6. Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People With Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIV
7. Differences in location of cerebral white matter hyperintensities in children and adults living with a treated HIV infection: A retrospective cohort comparison
8. Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus–Infected Individuals in a High-income Setting
9. Neurocognitive Development in Perinatally Human Immunodeficiency Virus–infected Adolescents on Long-term Treatment, Compared to Healthy Matched Controls: A Longitudinal Study
10. Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study
11. Compliance with laboratory monitoring guidelines in outpatient HIV care: a qualitative study in the Netherlands
12. AIDS Therapy Evaluation in the Netherlands (ATHENA) national observational HIV cohort: cohort profile
13. CNS penetration of ART in HIV-infected children
14. Cigarette Smoking and Inflammation, Monocyte Activation, and Coagulation in HIV-Infected Individuals Receiving Antiretroviral Therapy, Compared With Uninfected Individuals
15. Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1–Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency
16. The Eye as a Window to the Brain: Neuroretinal Thickness Is Associated With Microstructural White Matter Injury in HIV-Infected Children
17. Virological and Social Outcomes of HIV-Infected Adolescents and Young Adults in The Netherlands Before and After Transition to Adult Care
18. HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-Infection: A Comparative Cohort Study
19. Retinal Structure and Function in Perinatally HIV-Infected and cART-Treated Children: A Matched Case–Control Study
20. Mortality risk factors among HIV-exposed infants in rural and urban Cameroon
21. Effect of Health Insurance and Facility Quality Improvement on Blood Pressure in Adults With Hypertension in Nigeria
22. Hypertension in Sub-Saharan Africa: Cross-Sectional Surveys in Four Rural and Urban Communities
23. Implementation of an Antiretroviral Access Program for HIV-1-Infected Individuals in Resource-Limited Settings
24. Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients
25. When to start antiretroviral therapy and what to start with—a European perspective
26. CC Chemokine Receptor 5 Δ32 and CC Chemokine Receptor 2 64I Polymorphisms Do Not Influence the Virologic and Immunologic Response to Antiretroviral Combination Therapy in Human Immunodeficiency Virus Type 1–Infected Patients
27. Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination Therapy
28. Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell loss
29. Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy
30. Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine
31. The ADAM study continued: maintenance therapy after 50 weeks of induction therapy
32. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection
33. T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy
34. T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy
35. The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals
36. Outcome and Predictors of Failure of Highly Active Antiretroviral Therapy: One‐Year Follow‐Up of a Cohort of Human Immunodeficiency Virus Type 1–Infected Persons
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.